1173C>T polymorphism in VKORC1 modulates the required warfarin dose

Kenjiro Kosaki, C. Yamaghishi, R. Sato, H. Semejima, H. Fuijita, K. Tamura, K. Maeyama, Hiroyuki Yamagishi, A. Sugaya, H. Dodo, Yusuke Tanigawara, Takao Takahashi

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

The response to warfarin is highly variable among individuals and such variability is likely to have some genetic basis. We evaluted the effect of VKORC1 polymorphisms on warfarin response among Japanese, taking advantage of its unique population structure in which CYP2C9*2 and*3 alleles are relatively rare. Thirty-one patients (12-34 years old; median, 22) on warfarin were recruited from a pediatric cardiology clinic. Genotyping of the C>T polymorphism at position 1173 in intron 1 of VKORC1 revealed that 26 patients (84%) were T/T homozygotes at nucleotide 1173, whereas 5 (16%) were C/T heterozygotes. Complete linkage disequilibrium was observed between the 1173C > T polymorphism and another polymorphism, the 3730G > A, in the 3′ untranslated region. The C/T heterozyogtes at the 1173C > T polymorphism tended to require more warfarin than the T/T homozygotes, when adjusted for international normalized ratio (p = 0.003). Both the 1173C > T polymorphism and the 3730G > A polymorphism are likely to be inert from a functional standpoint. Rather, based on the complete linkage disequilibrium between 1173C > T and 3730G > A polymorphisms, we suspect that the actual change that defines the relative resistance to warfarin may be present in the proximity of these two polymorphisms.

Original languageEnglish
Pages (from-to)685-688
Number of pages4
JournalPediatric Cardiology
Volume27
Issue number6
DOIs
Publication statusPublished - 2006 Dec

Fingerprint

Warfarin
Linkage Disequilibrium
Homozygote
International Normalized Ratio
3' Untranslated Regions
Heterozygote
Cardiology
Introns
Nucleotides
Alleles
Pediatrics
Population

Keywords

  • Pharmacogenetics
  • Polymorphism
  • Vitamin K
  • Warfarin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

1173C>T polymorphism in VKORC1 modulates the required warfarin dose. / Kosaki, Kenjiro; Yamaghishi, C.; Sato, R.; Semejima, H.; Fuijita, H.; Tamura, K.; Maeyama, K.; Yamagishi, Hiroyuki; Sugaya, A.; Dodo, H.; Tanigawara, Yusuke; Takahashi, Takao.

In: Pediatric Cardiology, Vol. 27, No. 6, 12.2006, p. 685-688.

Research output: Contribution to journalArticle

Kosaki, K, Yamaghishi, C, Sato, R, Semejima, H, Fuijita, H, Tamura, K, Maeyama, K, Yamagishi, H, Sugaya, A, Dodo, H, Tanigawara, Y & Takahashi, T 2006, '1173C>T polymorphism in VKORC1 modulates the required warfarin dose', Pediatric Cardiology, vol. 27, no. 6, pp. 685-688. https://doi.org/10.1007/s00246-005-1150-x
Kosaki K, Yamaghishi C, Sato R, Semejima H, Fuijita H, Tamura K et al. 1173C>T polymorphism in VKORC1 modulates the required warfarin dose. Pediatric Cardiology. 2006 Dec;27(6):685-688. https://doi.org/10.1007/s00246-005-1150-x
Kosaki, Kenjiro ; Yamaghishi, C. ; Sato, R. ; Semejima, H. ; Fuijita, H. ; Tamura, K. ; Maeyama, K. ; Yamagishi, Hiroyuki ; Sugaya, A. ; Dodo, H. ; Tanigawara, Yusuke ; Takahashi, Takao. / 1173C>T polymorphism in VKORC1 modulates the required warfarin dose. In: Pediatric Cardiology. 2006 ; Vol. 27, No. 6. pp. 685-688.
@article{3c9838081e0d49c68d8a4b36d120a744,
title = "1173C>T polymorphism in VKORC1 modulates the required warfarin dose",
abstract = "The response to warfarin is highly variable among individuals and such variability is likely to have some genetic basis. We evaluted the effect of VKORC1 polymorphisms on warfarin response among Japanese, taking advantage of its unique population structure in which CYP2C9*2 and*3 alleles are relatively rare. Thirty-one patients (12-34 years old; median, 22) on warfarin were recruited from a pediatric cardiology clinic. Genotyping of the C>T polymorphism at position 1173 in intron 1 of VKORC1 revealed that 26 patients (84{\%}) were T/T homozygotes at nucleotide 1173, whereas 5 (16{\%}) were C/T heterozygotes. Complete linkage disequilibrium was observed between the 1173C > T polymorphism and another polymorphism, the 3730G > A, in the 3′ untranslated region. The C/T heterozyogtes at the 1173C > T polymorphism tended to require more warfarin than the T/T homozygotes, when adjusted for international normalized ratio (p = 0.003). Both the 1173C > T polymorphism and the 3730G > A polymorphism are likely to be inert from a functional standpoint. Rather, based on the complete linkage disequilibrium between 1173C > T and 3730G > A polymorphisms, we suspect that the actual change that defines the relative resistance to warfarin may be present in the proximity of these two polymorphisms.",
keywords = "Pharmacogenetics, Polymorphism, Vitamin K, Warfarin",
author = "Kenjiro Kosaki and C. Yamaghishi and R. Sato and H. Semejima and H. Fuijita and K. Tamura and K. Maeyama and Hiroyuki Yamagishi and A. Sugaya and H. Dodo and Yusuke Tanigawara and Takao Takahashi",
year = "2006",
month = "12",
doi = "10.1007/s00246-005-1150-x",
language = "English",
volume = "27",
pages = "685--688",
journal = "Pediatric Cardiology",
issn = "0172-0643",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - 1173C>T polymorphism in VKORC1 modulates the required warfarin dose

AU - Kosaki, Kenjiro

AU - Yamaghishi, C.

AU - Sato, R.

AU - Semejima, H.

AU - Fuijita, H.

AU - Tamura, K.

AU - Maeyama, K.

AU - Yamagishi, Hiroyuki

AU - Sugaya, A.

AU - Dodo, H.

AU - Tanigawara, Yusuke

AU - Takahashi, Takao

PY - 2006/12

Y1 - 2006/12

N2 - The response to warfarin is highly variable among individuals and such variability is likely to have some genetic basis. We evaluted the effect of VKORC1 polymorphisms on warfarin response among Japanese, taking advantage of its unique population structure in which CYP2C9*2 and*3 alleles are relatively rare. Thirty-one patients (12-34 years old; median, 22) on warfarin were recruited from a pediatric cardiology clinic. Genotyping of the C>T polymorphism at position 1173 in intron 1 of VKORC1 revealed that 26 patients (84%) were T/T homozygotes at nucleotide 1173, whereas 5 (16%) were C/T heterozygotes. Complete linkage disequilibrium was observed between the 1173C > T polymorphism and another polymorphism, the 3730G > A, in the 3′ untranslated region. The C/T heterozyogtes at the 1173C > T polymorphism tended to require more warfarin than the T/T homozygotes, when adjusted for international normalized ratio (p = 0.003). Both the 1173C > T polymorphism and the 3730G > A polymorphism are likely to be inert from a functional standpoint. Rather, based on the complete linkage disequilibrium between 1173C > T and 3730G > A polymorphisms, we suspect that the actual change that defines the relative resistance to warfarin may be present in the proximity of these two polymorphisms.

AB - The response to warfarin is highly variable among individuals and such variability is likely to have some genetic basis. We evaluted the effect of VKORC1 polymorphisms on warfarin response among Japanese, taking advantage of its unique population structure in which CYP2C9*2 and*3 alleles are relatively rare. Thirty-one patients (12-34 years old; median, 22) on warfarin were recruited from a pediatric cardiology clinic. Genotyping of the C>T polymorphism at position 1173 in intron 1 of VKORC1 revealed that 26 patients (84%) were T/T homozygotes at nucleotide 1173, whereas 5 (16%) were C/T heterozygotes. Complete linkage disequilibrium was observed between the 1173C > T polymorphism and another polymorphism, the 3730G > A, in the 3′ untranslated region. The C/T heterozyogtes at the 1173C > T polymorphism tended to require more warfarin than the T/T homozygotes, when adjusted for international normalized ratio (p = 0.003). Both the 1173C > T polymorphism and the 3730G > A polymorphism are likely to be inert from a functional standpoint. Rather, based on the complete linkage disequilibrium between 1173C > T and 3730G > A polymorphisms, we suspect that the actual change that defines the relative resistance to warfarin may be present in the proximity of these two polymorphisms.

KW - Pharmacogenetics

KW - Polymorphism

KW - Vitamin K

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=33845509489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845509489&partnerID=8YFLogxK

U2 - 10.1007/s00246-005-1150-x

DO - 10.1007/s00246-005-1150-x

M3 - Article

VL - 27

SP - 685

EP - 688

JO - Pediatric Cardiology

JF - Pediatric Cardiology

SN - 0172-0643

IS - 6

ER -